Ascendis Pharma A/S Profit Loss Attributable To Owners Of Parent
Ascendis Pharma A/S (ASND) reported Profit Loss Attributable To Owners Of Parent of -EUR 228.03 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:ProfitLossAttributableToOwnersOfParent · last filed 2026-02-11
- Ascendis Pharma A/S profit loss attributable to owners of parent for the quarter ending 2025-12-31 was -33.56M EUR.
- Ascendis Pharma A/S profit loss attributable to owners of parent for the quarter ending 2025-09-30 was -60.99M EUR.
- Ascendis Pharma A/S profit loss attributable to owners of parent for the quarter ending 2025-06-30 was -38.85M EUR.
- Ascendis Pharma A/S profit loss attributable to owners of parent for the quarter ending 2025-03-31 was -94.63M EUR.
| Period end | Profit Loss Attributable To Owners Of Parent 3 month | Profit Loss Attributable To Owners Of Parent 6 month | Profit Loss Attributable To Owners Of Parent 9 month | Profit Loss Attributable To Owners Of Parent 12 month |
|---|---|---|---|---|
| 2025-12-31 | -33.56M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -94.55M EUR derived: sum of 2 quarters · filed 2026-02-11 | -133.41M EUR derived: sum of 3 quarters · filed 2026-02-11 | -228.03M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | -60.99M EUR 6-K · filed 2025-11-12 | -99.84M EUR derived: sum of 2 quarters · filed 2025-11-12 | -194.47M EUR 6-K · filed 2025-11-12 | -232.94M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | -38.85M EUR 6-K · filed 2025-08-07 | -133.48M EUR 6-K · filed 2025-08-07 | -171.95M EUR derived: sum of 3 quarters · filed 2026-02-11 | -271.15M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | -94.63M EUR 6-K · filed 2025-05-01 | -133.09M EUR derived: sum of 2 quarters · filed 2026-02-11 | -232.29M EUR derived: sum of 3 quarters · filed 2026-02-11 | -341.67M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | -38.47M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -137.67M EUR derived: sum of 2 quarters · filed 2026-02-11 | -247.05M EUR derived: sum of 3 quarters · filed 2026-02-11 | -378.08M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | -99.20M EUR 6-K · filed 2025-11-12 | -208.58M EUR derived: sum of 2 quarters · filed 2025-11-12 | -339.62M EUR 6-K · filed 2025-11-12 | -426.49M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -109.38M EUR 6-K · filed 2025-08-07 | -240.41M EUR 6-K · filed 2025-08-07 | -327.29M EUR derived: sum of 3 quarters · filed 2026-02-11 | -489.52M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -131.03M EUR 6-K · filed 2025-05-01 | -217.91M EUR derived: sum of 2 quarters · filed 2026-02-11 | -380.14M EUR derived: sum of 3 quarters · filed 2026-02-11 | -501.57M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -86.88M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -249.10M EUR derived: sum of 2 quarters · filed 2026-02-11 | -370.53M EUR derived: sum of 3 quarters · filed 2026-02-11 | -481.45M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | -162.22M EUR 6-K · filed 2024-11-14 | -283.66M EUR derived: sum of 2 quarters · filed 2024-11-14 | -394.57M EUR 6-K · filed 2024-11-14 | -601.99M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -121.43M EUR 6-K · filed 2024-09-03 | -232.35M EUR 6-K · filed 2024-09-03 | -439.76M EUR derived: sum of 3 quarters · filed 2025-02-12 | -608.72M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -110.91M EUR 6-K · filed 2024-05-02 | -318.33M EUR derived: sum of 2 quarters · filed 2025-02-12 | -487.29M EUR derived: sum of 3 quarters · filed 2025-02-12 | -568.61M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -207.42M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | -376.37M EUR derived: sum of 2 quarters · filed 2025-02-12 | -457.69M EUR derived: sum of 3 quarters · filed 2025-02-12 | -583.19M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | -168.96M EUR 6-K · filed 2023-11-07 | -250.27M EUR derived: sum of 2 quarters · filed 2023-11-07 | -375.78M EUR 6-K · filed 2023-11-07 | -481.83M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -81.32M EUR 6-K · filed 2023-09-05 | -206.82M EUR 6-K · filed 2023-09-05 | -312.88M EUR derived: sum of 3 quarters · filed 2024-02-07 | -393.23M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | -125.50M EUR 6-K · filed 2023-04-27 | -231.56M EUR derived: sum of 2 quarters · filed 2024-02-07 | -311.91M EUR derived: sum of 3 quarters · filed 2024-02-07 | -446.28M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -106.06M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | -186.41M EUR derived: sum of 2 quarters · filed 2024-02-07 | -320.78M EUR derived: sum of 3 quarters · filed 2024-02-07 | -383.58M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | -80.35M EUR 6-K · filed 2022-11-02 | -214.72M EUR derived: sum of 2 quarters · filed 2022-11-02 | -277.51M EUR 6-K · filed 2022-11-02 | -416.48M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -134.37M EUR 6-K · filed 2022-08-10 | -197.17M EUR 6-K · filed 2022-08-10 | -336.13M EUR derived: sum of 3 quarters · filed 2023-02-16 | -457.87M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -62.79M EUR 6-K · filed 2022-05-11 | -201.76M EUR derived: sum of 2 quarters · filed 2023-02-16 | -323.50M EUR derived: sum of 3 quarters · filed 2023-02-16 | -418.43M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -138.97M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | -260.71M EUR derived: sum of 2 quarters · filed 2023-02-16 | -355.64M EUR derived: sum of 3 quarters · filed 2023-02-16 | -418.95M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | -121.74M EUR 6-K · filed 2021-11-10 | -216.67M EUR derived: sum of 2 quarters · filed 2021-11-10 | -279.99M EUR 6-K · filed 2021-11-10 | -360.35M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | -94.93M EUR 6-K · filed 2021-08-27 | -158.25M EUR 6-K · filed 2021-08-27 | -238.61M EUR derived: sum of 3 quarters · filed 2022-03-02 | -263.72M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | -63.32M EUR 6-K · filed 2021-05-27 | -143.68M EUR derived: sum of 2 quarters · filed 2022-03-02 | -168.79M EUR derived: sum of 3 quarters · filed 2022-03-02 | -227.70M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | -80.36M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | -105.47M EUR derived: sum of 2 quarters · filed 2022-03-02 | -164.38M EUR derived: sum of 3 quarters · filed 2022-03-02 | -218.02M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | -25.11M EUR 6-K · filed 2020-11-12 | -84.02M EUR derived: sum of 2 quarters · filed 2020-11-12 | -137.65M EUR 6-K · filed 2020-11-12 | |
| 2019-06-30 | -58.90M EUR 6-K · filed 2020-08-27 | -112.54M EUR 6-K · filed 2020-08-27 | ||
| 2018-12-31 | -130.10M EUR 20-F · filed 2021-03-10 |